This trial tests a new way to help people stick to a smoking cessation program. The treatment offers subjects the chance to forego a monetary incentive in exchange for abstaining from smoking.
3 Primary · 4 Secondary · Reporting Duration: 14 days following intake date, as well as 1 month and 6 months after intake date
2 Treatment Groups
1 of 2
1 of 2
200 Total Participants · 2 Treatment Groups
Primary Treatment: Contingency Management · Has Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any opportunities available to join this research initiative?
"Data from clinicaltrials.gov confirms that this medical study is currently accepting patients, with the initial posting having taken place on October 13th 2021 and a subsequent edit made not long ago (October 7th 2022)." - Anonymous Online Contributor
What is the primary objective of this clinical investigation?
"The primary purpose of this trial, estimated to last 14 days from the intake date, is to measure Breath Carbon Monoxide Test (ppm levels). Secondary objectives include Reduced Smoking - quantified by reported changes in smoking habits; Contingency Management Payments - evaluated via total abstention rewards administered; and Time to First Relapse – documented through self-reported use of nicotine products or cigarette alternatives." - Anonymous Online Contributor
How many individuals are currently participating in this clinical experiment?
"Affirmative, clinicaltrials.gov data shows that this trial is actively searching for participants. It was first posted on October 13th 2021 and last updated on October 7th 2022, with a goal of recruiting 200 people from one particular location." - Anonymous Online Contributor